The relationship between serum tumor-associated trypsin inhibitor levels and clinicopathological parameters in patients with gastric cancer

Kemik, Özgür; Kemik, A.; SUMER, Aziz; Almalı, Necat; Gurluler, E.; Gures, N.; Purisa, S.; ADAS, G.; DOGAN, Y.; TUZUN, S.

The relationship between serum tumor-associated trypsin inhibitor levels and clinicopathological parameters in patients with gastric cancer

Kemik Ö. , Kemik A., SUMER A. , Almalı N. , Gurluler E., Gures N., ...More

EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, vol.17, no.21, pp.2923-2928, 2013 (Journal Indexed in SCI)

Publication Type: Article / Article
Volume: 17 Issue: 21
Publication Date: 2013
Title of Journal : EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES
Page Numbers: pp.2923-2928

Abstract

BACKGROUND: Tumor-associated trypsin inhibitor (TATI) is expressed with trypsinogen in tumors. We studied the clinical-pathologic association and significance of preoperative serum levels of TATI in gastric cancer patients.